Shanghai OPM Biosciences Co., Ltd. (SHA:688293)

Market Cap	5.11B
Revenue (ttm)	301.21M
Net Income (ttm)	16.14M
Shares Out	113.55M
EPS (ttm)	0.14
PE Ratio	316.62
Forward PE	66.19
Dividend	0.42 (1.04%)
Ex-Dividend Date	May 23, 2025

Volume	446,344
Average Volume	669,582
Open	39.15
Previous Close	39.38
Day's Range	39.15 - 40.59
52-Week Range	24.50 - 48.67
Beta	0.58
RSI	66.62
Earnings Date	Aug 23, 2025

About Shanghai OPM Biosciences

Shanghai OPM Biosciences Co., Ltd. provides cell culture media and CDMO services in China and internationally. The company offers OPM cell culture media services, including OPM-CHO platform, OPM-293 platform, OPM-VAC platform, OPM-Hybri platform, and classical media; customized media solutions; and OEM media manufacturing services. It also provides end-to-end biologics CDMO services, such as antibody discovery, stable cell line development & cell banking platform, upstream process development, downstream process development, OPM formulation dev...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2013
• Employees: 328
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688293

Financial Performance

In 2024, Shanghai OPM Biosciences's revenue was 297.24 million, an increase of 22.26% compared to the previous year's 243.12 million. Earnings were 21.05 million, a decrease of -61.04%.